These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21515744)

  • 1. Dual-monoclonal, sandwich immunoassay specific for glucose-dependent insulinotropic peptide1-42, the active form of the incretin hormone.
    Troutt JS; Siegel RW; Chen J; Sloan JH; Deeg MA; Cao G; Konrad RJ
    Clin Chem; 2011 Jun; 57(6):849-55. PubMed ID: 21515744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual-monoclonal, sandwich immunoassay specific for glucagon like peptide-19-36/7 (GLP-19-36/7).
    Osborne RI; Ming W; Troutt JS; Siegel RW; Konrad RJ
    Clin Biochem; 2016 Aug; 49(12):897-902. PubMed ID: 27208557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.
    Deacon CF; Wamberg S; Bie P; Hughes TE; Holst JJ
    J Endocrinol; 2002 Feb; 172(2):355-62. PubMed ID: 11834453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of novel specific assay for short-form glucose-dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects.
    Takeda Y; Fujita Y; Yanagimachi T; Maruyama N; Bessho R; Sakagami H; Honjo J; Yokoyama H; Haneda M
    Physiol Rep; 2020 Jun; 8(11):e14469. PubMed ID: 32472669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects.
    Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Sakagami H; Kitsunai H; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M
    Mol Metab; 2017 Feb; 6(2):226-231. PubMed ID: 28180064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
    Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
    Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
    Matsumoto T; Harada N; Azuma M; Chihara Y; Murase K; Tachikawa R; Minami T; Hamada S; Tanizawa K; Inouchi M; Oga T; Mishima M; Chin K
    Ann Am Thorac Soc; 2016 Aug; 13(8):1378-87. PubMed ID: 27104640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassays for the incretin hormones GIP and GLP-1.
    Deacon CF; Holst JJ
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):425-32. PubMed ID: 19748060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.
    Prévost G; Ducrotté P; Cailleux A; Khalfi K; Basuyau JP; Lefebvre H; Kuhn JM
    Neurogastroenterol Motil; 2013 Aug; 25(8):694-9. PubMed ID: 23663508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incretin effect does not differ in trained and untrained, young, healthy men.
    Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
    Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin levels in polycystic ovary syndrome.
    Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
    Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
    Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
    Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
    Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
    Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.
    Mentlein R; Gallwitz B; Schmidt WE
    Eur J Biochem; 1993 Jun; 214(3):829-35. PubMed ID: 8100523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin secretion in humans is under the influence of cannabinoid receptors.
    Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soya milk exerts different effects on plasma amino acid responses and incretin hormone secretion compared with cows' milk in healthy, young men.
    Sun L; Tan KW; Siow PC; Henry CJ
    Br J Nutr; 2016 Oct; 116(7):1216-1221. PubMed ID: 27609509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.